Share Price | Goldline Pharmaceutical Ltd Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

1.17 lacs (-8.02%) Volume

Shareholding (May 2026)

FII

0.00%

Held by 0 FIIs

DII

20.29%

Held by 0 DIIs

Promoter

79.71%

Why is Goldline Pharmac falling/rising?

09-Jun-2026

As of 08-Jun, Goldline Pharmaceutical Ltd's stock price is falling, currently at 44.20, reflecting a bearish trend with significant underperformance and decreased investor participation. The stock is trading below all major moving averages, indicating a lack of confidence among investors.

View full answer

Which are the latest news on Goldline Pharmac?

09-Jun-2026

No latest news for Goldline Pharmac found.

Compare Goldline Pharmac with Similar Stocks

Rajnish Wellness Sandu Pharma.Mangalam Drugs

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

INR 42 Cr (Micro Cap)

P/E

15.00

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.73

Return on Equity

27.33%

Price to Book

4.10

Revenue and Profits:

Net Sales:

(Quarterly Results - )

Net Profit:

Total Returns

Total Returns (Price + Dividend)

Company does not have enough history

Risk Adjusted Returns v/s

Returns Beta

Beta has not been calculated since enough price history is not available

News & Corporate Actions

News

No Recent News for the Company

Announcements

Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 To Be Held On Tuesday June 09 2026.

02-Jun-2026 | Source : BSE

Goldline Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/06/2026 inter alia to consider and approve Standalone Audited financials results for the half year and year ended 31st March 2026.

Listing of Equity Shares of Goldline Pharmaceutical Ltd

19-May-2026 | Source : BSE

Trading Members of the Exchange are hereby informed that effective from May 19 2026 the Equity Shares of Goldline Pharmaceutical Ltd (Scrip Code: 544759) are listed and admitted to dealings on the Exchange in the list of MT Group Securities. For further details please refer to the notice no. 20260518- dated May 18 2026.

Corporate Actions

BOARD MEETING

No Upcoming Board Meetings

DIVIDEND

No Dividend history available

SPLITS

No Splits history available

BONUS

No Bonus history available

RIGHTS

No Rights history available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

EBIT Growth (5y)

EBIT to Interest (avg)

2.91

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

26.42%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

20.29%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.05

EV to EBIT

8.86

EV to EBITDA

8.48

EV to Capital Employed

2.76

EV to Sales

1.76

PEG Ratio

Dividend Yield

ROCE (Latest)

31.13%

ROE (Latest)

27.33%

Technicals key factors

Indicator

Weekly

Monthly

Technical indicator has not been calculated since the stock has been active for a short period

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : May 2026

Shareholding Compare (%holding)

Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Swapan Premprakash Khandelwal (39.85%)

Highest Public shareholder

Sumit Bilgaiyan (7.03%)

Individual Investors Holdings

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by Goldline Pharmac"
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Goldline Pharmac"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Goldline Pharmac"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "alert": "No Annual Results declared by Goldline Pharmac"
  }
]

Company CV

About Goldline Pharmaceutical Ltd

Goldline Pharmaceutical Ltd

Micro Cap

Pharmaceuticals & Biotechnology

Goldline Pharmaceutical Limited was originally incorporated on August 2, 2004, as a private limited Company in the name of `Goldline Pharmaceutical Private Limited' with the Registrar of Companies, Mumbai. Subsequently, Company was converted into a public limited Company and the name of Company was changed to `Goldline Pharmaceutical Limited' w.e.f. September 23, 2013. Company is engaged in the business of marketing pharmaceutical products under the Goldline brand.

Company Coordinates

No Company Details Available